BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 21307785)

  • 21. Camptocormia in Parkinson's disease: definition, epidemiology, pathogenesis and treatment modalities.
    Srivanitchapoom P; Hallett M
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):75-85. PubMed ID: 25896683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Camptocormia in a patient with Parkinson disease: beneficial effects of pallidal deep brain stimulation. Case report.
    Micheli F; Cersósimo MG; Piedimonte F
    J Neurosurg; 2005 Dec; 103(6):1081-3. PubMed ID: 16381196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subthalamic nucleus stimulation improves Parkinson's disease-associated camptocormia in parallel to its preoperative levodopa responsiveness.
    Yamada K; Shinojima N; Hamasaki T; Kuratsu J
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):703-9. PubMed ID: 26424897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of camptocormia on lung volumes in Parkinson's disease.
    Marinelli P; Colosimo C; Ferrazza AM; Di Stasio F; Fabbrini G; Palange P; Berardelli A
    Respir Physiol Neurobiol; 2013 Jun; 187(2):164-6. PubMed ID: 23570958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cross-Sectional Area of Paraspinal Muscles Predicts the Efficacy of Deep Drain Stimulation for Camptocormia.
    Sakai W; Nakane S; Urasaki E; Toyoda K; Sadakata E; Nagaishi A; Fukudome T; Yamakawa Y; Matsuo H
    J Parkinsons Dis; 2017; 7(2):247-253. PubMed ID: 28157107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic criteria for camptocormia in Parkinson's disease: A consensus-based proposal.
    Fasano A; Geroin C; Berardelli A; Bloem BR; Espay AJ; Hallett M; Lang AE; Tinazzi M
    Parkinsonism Relat Disord; 2018 Aug; 53():53-57. PubMed ID: 29759930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Camptocormia: New Signs in an Old Syndrome.
    Tatu L; Bogousslavsky J
    Front Neurol Neurosci; 2018; 42():87-95. PubMed ID: 29151099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.
    Schulz-Schaeffer WJ; Margraf NG; Munser S; Wrede A; Buhmann C; Deuschl G; Oehlwein C
    Mov Disord; 2015 Mar; 30(3):368-72. PubMed ID: 25678310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Camptocormia disclosing Parkinson's disease].
    Bouzgarou E; Dupeyron A; Castelnovo G; Boudousq V; Collombier L; Labauge P; Pélissier J
    Ann Readapt Med Phys; 2007 Jan; 50(1):55-9. PubMed ID: 17027115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case report of thoracolumbar paraspinal myopathy as the cause of camptocormia in a patient with atypical parkinsonism.
    Kim Y; Kim A; Kim A; Jeon B
    BMC Neurol; 2017 Jun; 17(1):118. PubMed ID: 28645253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson's disease.
    Sako W; Nishio M; Maruo T; Shimazu H; Matsuzaki K; Tamura T; Mure H; Ushio Y; Nagahiro S; Kaji R; Goto S
    Mov Disord; 2009 May; 24(7):1076-9. PubMed ID: 19353719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Camptocormia: pathogenesis, classification, and response to therapy.
    Azher SN; Jankovic J
    Neurology; 2005 Aug; 65(3):355-9. PubMed ID: 16087897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Camptocormia or Pisa syndrome in multiple system atrophy.
    Sławek J; Derejko M; Lass P; Dubaniewicz M
    Clin Neurol Neurosurg; 2006 Oct; 108(7):699-704. PubMed ID: 16112411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-induced camptocormia and dropped head syndrome: Review and case report of radiation-induced movement disorders.
    Seidel C; Kuhnt T; Kortmann RD; Hering K
    Strahlenther Onkol; 2015 Oct; 191(10):765-70. PubMed ID: 26072168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Camptocormia in a patient with Parkinson disease and a myopathy with nemaline rods.
    Ozer F; Ozturk O; Meral H; Serdaroglu P; Yayla V
    Am J Phys Med Rehabil; 2007 Jan; 86(1):3-6. PubMed ID: 17304682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical management of camptocormia in Parkinson's disease: systematic review and meta-analysis.
    Chan AK; Chan AY; Lau D; Durcanova B; Miller CA; Larson PS; Starr PA; Mummaneni PV
    J Neurosurg; 2018 Sep; 131(2):368-375. PubMed ID: 30215560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe camptocormia due to myositis of paraspinal muscles as an early manifestation of Parkinson's disease.
    Whittaker K; Schroeter N; Rijntjes M; Guggenberger K; Lambeck J; Fritsch B; Weiller C; Meyer PT; Doostkam S; Klebe S
    Parkinsonism Relat Disord; 2018 Jan; 46():95-97. PubMed ID: 29174169
    [No Abstract]   [Full Text] [Related]  

  • 38. Pallidal vs subthalamic deep brain stimulation for Parkinson disease.
    Komotar RJ; Starke RM; Connolly ES; Goodman RR
    Neurosurgery; 2010 Oct; 67(4):N25-7. PubMed ID: 20881548
    [No Abstract]   [Full Text] [Related]  

  • 39. [Camptocormia and Parkinson's disease: association or consequence?].
    Frioui S; Jemni S
    Pan Afr Med J; 2015; 20():339. PubMed ID: 26175829
    [No Abstract]   [Full Text] [Related]  

  • 40. Alleviation of camptocormia by bilateral subthalamic nucleus stimulation in a patient with Parkinson's disease.
    Yamada K; Goto S; Matsuzaki K; Tamura T; Murase N; Shimazu H; Nagahiro S; Kuratsu J; Kaji R
    Parkinsonism Relat Disord; 2006 Sep; 12(6):372-5. PubMed ID: 16731023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.